2013

Advances in Biology and Therapy of Multiple Myeloma

Volume 2: Translational and Clinical Research

Editors:

ISBN: 978-1-4614-5259-1 (Print) 978-1-4614-5260-7 (Online)

Table of contents (11 chapters)

  1. Front Matter

    Pages i-x

  2. Myeloma Immune and Antibody Targets

    1. Front Matter

      Pages 1-1

    2. No Access

      Book Chapter

      Pages 3-24

      T Cell Responses in Myeloma

    3. No Access

      Book Chapter

      Pages 25-42

      Novel Antigenic Targets for Immunotherapy in Myeloma

    4. No Access

      Book Chapter

      Pages 43-71

      Antibody-Based Therapies in Multiple Myeloma

    5. No Access

      Book Chapter

      Pages 73-110

      Defining Multiple Myeloma as a Target for DNA Vaccines

    6. No Access

      Book Chapter

      Pages 111-129

      Harnessing Allogeneic Immunity for Anti-myeloma Response

    7. No Access

      Book Chapter

      Pages 131-154

      Dendritic Cells and Peptide-Based Vaccine In Multiple Myeloma

  3. New Agents

    1. Front Matter

      Pages 155-155

    2. No Access

      Book Chapter

      Pages 157-180

      Novel Proteasome Inhibitors

    3. No Access

      Book Chapter

      Pages 181-213

      Newer IMiDs

    4. No Access

      Book Chapter

      Pages 215-228

      Novel Agents in Multiple Myeloma

    5. No Access

      Book Chapter

      Pages 229-255

      Early Combination Studies in Multiple Myeloma

    6. No Access

      Book Chapter

      Pages 257-275

      The Effect of Novel Anti-myeloma Agents on Bone Metabolism

  4. Back Matter

    Pages 277-287